|
Cholera Pathogen Reveals How Bacteria Generate Energy To Live
Troy, N.Y. — Researchers at Rensselaer Polytechnic Institute
have discovered new details about how bacteria generate energy
to live. In two recently published papers, the scientists add
key specifics to the molecular mechanism behind the pathogen
that causes cholera. The work could provide a better
understanding of this pathogen, while also offering insight
into how cells transform energy from the environment into the
forms required to sustain life.
As a single-cell organism, Vibrio cholerae depends
on resources in its immediate environment to sustain itself.
Blanca Barquera, assistant professor of biology at Rensselaer
and principal investigator for the project, studies an enzyme
that resides in the membrane that encapsulates V.
cholerae. This enzyme, known as NQR, pumps sodium ions out
of the bacteria to generate a difference in concentrations
between outside and inside. This gradient acts like a battery
that powers essential cell functions, such as the movement of
the bacterium’s tail, the flagellum.
Most cells, including human cells, use gradients of protons
for this energy conservation function, but enzymes that work
with sodium ions are ideal for experimental study, according to
Barquera. Sodium is easier to trace and its concentration can
be changed without affecting pH, which is a complication with
protons. “It’s a very good system to understand this very basic
mechanism charging this battery to create energy,” she
said.
In order to learn how the enzyme works, researchers are
trying to get an idea of its three-dimensional structure. “The
enzyme is like two machines together — imagine the turbine and
generator of a hydroelectric dam. One is the source of energy;
the other uses this energy to pump ions out of the cell,”
Barquera said. How the two machines are connected is one key
question.
In the first paper, published in the Journal of
Bacteriology, Barquera tackled the question of how the
structure of the enzyme is organized with respect to the two
sides of the membrane. The problem is that the enzyme is not
amenable to standard methods of determining structure. Since an
ion pump needs to carry ions from one side of the bacterial
membrane to the other, the enzyme has to reach all the way from
the water-like medium inside the cell, through the oily
membrane interior, to the water-like environment outside the
cell. For this reason, the enzyme is made up of
water-soluble and oil-soluble components within a single
entity, so it can’t hold its shape in any one
solvent.
Using a stepwise process, Barquera attached labels at
significant points along the length of the protein and then
determined whether these labels appeared inside or outside the
envelope of the cell membrane. The results showed that the
cofactors — important parts of the enzyme’s machinery — are all
located on the inner side of the membrane, which corresponds to
the “intake” port of the ion pump.
The second paper was published in the Journal of
Biological Chemistry. In this study, Barquera focused on
structures, known as flavins, within the enzyme that carry the
electric current that drives the ion pump. Using an
interdisciplinary approach that combined genetic methods — to
modify the enzyme structure — with an analytical technique
known as Electron Paramagnetic Resonance Spectroscopy, which
observes electron spin, she and her co-worker Mark Nilges at
the University of Illinois analyzed the properties of the
flavin molecules, and mapped these functional properties to
specific points in the protein structure.
NQR is only one of several sodium pumping enzymes that
Barquera plans to study. Because these enzymes are
significantly different from human proteins that do similar
work, some of them might be targeted by novel antibiotics. “An
inhibitor or drug would be specific,” she said. “You could kill
the bacteria without doing anything to the human host.”
But Barquera believes that the most important benefits of
her research could develop in ways that cannot be
foreseen: “From the basic science point of view, the more
you know, the better,” Barquera said. “It’s basic science that
will take us to unexpected places.”
One of those unexpected places in Barquera’s career has been
her developing interest in the physiology and life cycle of
V. cholerae itself. Much of what is known about V.
cholerae is from study of the organism when it is in the body,
yet the bacteria spend most of their lives outside their hosts.
Study of the rest of the life cycle could be important in
disease prevention.
“We have to know the enemy,” Barquera said. As it stands,
“We are trying to kill our enemies with very little
knowledge.”
This research was funded by grants from the National
Institutes of Health.
Biotechnology and Interdisciplinary Studies at
Rensselaer
At Rensselaer, faculty and students in diverse academic and
research disciplines are collaborating at the intersection of
the life sciences, the physical sciences, and engineering to
encourage discovery and innovation. Rensselaer’s four
biotechnology research constellations — biocatalysis and
metabolic engineering, functional tissue engineering and
regenerative medicine, biocomputation and bioinformatics, and
integrative systems biology — engage a multidisciplinary mix of
faculty and students focused on the application of engineering
and physical and information sciences to the life sciences.
Ranked among the world’s most advanced research facilities, the
Center for Biotechnology and Interdisciplinary Studies at
Rensselaer provides a state-of-the-art platform for
collaborative research and world-class programs and
symposia.
Link
to printer-friendly pdf
|
Published
January 29,
2007 |
Contact: Jason Gorss
Phone: (518) 276-6098
E-mail: gorssj@rpi.edu |
|